Tenet Healthcare (NYSE:THC) Rating Lowered to “Buy” at Wall Street Zen

Tenet Healthcare (NYSE:THC) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday.

THC has been the topic of a number of other reports. UBS Group boosted their target price on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Raymond James Financial set a $245.00 price objective on shares of Tenet Healthcare in a research note on Wednesday, October 29th. Cantor Fitzgerald lifted their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. KeyCorp increased their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research report on Thursday, February 12th. Finally, JPMorgan Chase & Co. lifted their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $247.67.

Tenet Healthcare Stock Up 0.6%

Shares of NYSE THC opened at $229.56 on Friday. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The firm has a 50-day moving average price of $201.87 and a 200 day moving average price of $197.69. Tenet Healthcare has a 52 week low of $109.82 and a 52 week high of $235.77. The stock has a market capitalization of $19.96 billion, a price-to-earnings ratio of 14.82, a price-to-earnings-growth ratio of 1.13 and a beta of 1.45.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period last year, the company posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts anticipate that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This represents a 7.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 0.81% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Tenet Healthcare

Several large investors have recently added to or reduced their stakes in the business. Wedmont Private Capital grew its holdings in Tenet Healthcare by 2.5% in the 4th quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock valued at $422,000 after buying an additional 50 shares during the period. Baron Wealth Management LLC grew its holdings in Tenet Healthcare by 4.8% in the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock valued at $227,000 after purchasing an additional 52 shares during the period. Sagespring Wealth Partners LLC increased its position in Tenet Healthcare by 3.6% during the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock worth $313,000 after purchasing an additional 55 shares during the last quarter. Quadrant Capital Group LLC raised its stake in Tenet Healthcare by 0.7% during the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after purchasing an additional 58 shares during the period. Finally, Syon Capital LLC grew its stake in shares of Tenet Healthcare by 5.3% during the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock valued at $249,000 after buying an additional 63 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.